StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$20.50+0.91 (+4.65%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

Fortrea revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Fortrea's revenue for the twelve months ending Sep 30, 2026 was $2.67B, down 3.4% year over year. For fiscal 2025 it was $2.72B, up 1.0% from the year before. The highest annual figure on record is $3.06B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.72B+1.0%
FY2024Dec 31, 2024$2.70B-5.1%
FY2023Dec 31, 2023$2.84B+0.2%
FY2022Dec 31, 2022$2.84B-7.2%
FY2021Dec 31, 2021$3.06B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$691.50M-1.4%
Q2 FY2026Jun 30, 2026$678.20M-4.5%
Q1 FY2026Mar 31, 2026$636.50M-2.3%
Q4 FY2025Dec 31, 2025$660.50M-5.2%
Q3 FY2025Sep 30, 2025$701.30M+3.9%
Q2 FY2025Jun 30, 2025$710.30M+7.2%
Q1 FY2025Mar 31, 2025$651.30M-1.6%
Q4 FY2024Dec 31, 2024$697.00M-1.8%
Q3 FY2024Sep 30, 2024$674.90M-5.4%
Q2 FY2024Jun 30, 2024$662.40M-8.6%
Q1 FY2024Mar 31, 2024$662.10M-4.6%
Q4 FY2023Dec 31, 2023$709.70M+41.2%
Q3 FY2023Sep 30, 2023$713.80M-6.4%
Q2 FY2023Jun 30, 2023$725.10M-8.6%
Q1 FY2023Mar 31, 2023$693.90M–
Q4 FY2022Dec 31, 2022$502.60M–
Q3 FY2022Sep 30, 2022$762.30M–
Q2 FY2022Jun 30, 2022$793.10M–

More Fortrea figures

See a number that looks wrong?